| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202412
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
373.70 |
| Sales(₹ Cr.) |
2,013.20 |
NP (₹ Cr.) |
442.27 |
| NP Var% |
-25.00 |
Div% |
1,170.00 |
| CPS(₹) |
208.00 |
EPS (₹) |
192.00 |
| Traded Value(₹ Lakhs) |
71.01 |
52 Week High |
10,526.00 |
| 52 Week Low |
4,146.00 |
Price BSE |
5,855.00 |
| Price NSE |
5,854.00 |
Market Capital (₹ Cr.) |
13,484.53 |
| P/C Ratio |
28.20 |
P/E Ratio |
30.50 |
| Price Vs.BV |
15.67 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
514.90 |
| NP(₹ Cr.) |
85.32 |
NP Var % |
22.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
2,192.20 |
| OPM |
-8.42 |
NP |
421.55 |
| NP Var% |
-24.94 |
EPS |
192.04 |
| PE |
30.49 |
|
|